A long-term study tracking nearly 800 adults from middle age into later life has found that higher vitamin D levels in the bloodstream during midlife are associated with lower accumulations of tau protein in the brain over a decade and a half later — a key biological marker linked to Alzheimer’s disease.
The research, published in Neurology, followed 793 participants who were, on average, 39 years old and free of dementia at the outset. Blood samples taken at the start measured vitamin D concentrations, and approximately 16 years later, participants underwent brain imaging to assess levels of tau and amyloid-beta proteins. On average, participants had a vitamin D level of 38.1 nanograms per milliliter, though more than a third fell below the 30 ng/mL threshold often used to define insufficiency. Only about 5% reported taking vitamin D supplements.
Those with higher vitamin D levels in midlife showed significantly less tau buildup in later brain scans, particularly in regions known to be vulnerable early in Alzheimer’s progression — including the entorhinal cortex, parahippocampal gyrus, amygdala, and parts of the temporal lobe. This association remained after adjusting for age, sex, blood pressure, smoking, and depressive symptoms.
Importantly, no similar link was found between vitamin D levels and amyloid-beta accumulation, suggesting the nutrient may influence specific pathways in the neurodegenerative process rather than exerting a broad protective effect across all Alzheimer’s-related biomarkers.
Researchers emphasize that the study identifies a correlation, not causation. As Martin David Mulligan of the University of Galway noted, the findings do not prove that vitamin D reduces tau or lowers dementia risk — only that the two are statistically related over time. He cautioned that people with higher vitamin D levels might simply engage in other health-promoting behaviors that independently benefit brain health.
For more on this story, see Top 6 Anti-Aging Supplements to Gradual Signs of Aging & Galway Study Links Vitamin D to Lower Dementia Risk.
Still, the timing of the measurement — in midlife — is considered significant. As Mulligan and co-author Emer McGrath pointed out, this period may represent a window of opportunity where modifying risk factors like nutrition could have outsized impact on long-term neurological outcomes.
The study’s authors acknowledge a key limitation: vitamin D levels were measured only once at the beginning, leaving open the possibility that fluctuations over the 16-year interval could affect the results. They also did not establish a definitive threshold for what constitutes a protective level, though they defined “high” as above 30 ng/mL for analytical purposes.
Even as vitamin D is widely known for supporting bone strength and immune function, its role in brain health remains under investigation. Laboratory evidence suggests it may reduce neuroinflammation, counteract oxidative stress, and regulate enzymes involved in tau protein misfolding — and vitamin D receptors are present in the hippocampus, a region early affected in Alzheimer’s.
Experts stress that supplementation should not be pursued solely for dementia prevention based on this data. Instead, they recommend maintaining adequate vitamin D levels through sunlight, diet, or medical guidance as part of broader brain-healthy habits, especially during midlife when lifestyle interventions may still alter disease trajectories.
Does taking vitamin D supplements reduce dementia risk?
The study does not support this conclusion. Researchers found only an association between naturally higher midlife vitamin D levels and lower tau accumulation years later — not evidence that supplements cause this effect or prevent dementia.
Why focus on midlife for vitamin D measurement?
Researchers suggest midlife may be a critical period when modifying risk factors like nutrition could have a stronger influence on long-term brain health, potentially delaying or reducing early Alzheimer’s-related changes before symptoms appear.
Is low vitamin D now considered a risk factor for Alzheimer’s?
The study identifies low vitamin D in midlife as a potentially modifiable factor linked to higher tau burden later, but stops short of calling it a proven risk factor — emphasizing the need for further research to confirm causality.